Perceptions of Pregnancy and Contraceptive Use: An In-Depth Study of Women in Los Angeles Methadone Clinics.


Journal

Women's health issues : official publication of the Jacobs Institute of Women's Health
ISSN: 1878-4321
Titre abrégé: Womens Health Issues
Pays: United States
ID NLM: 9101000

Informations de publication

Date de publication:
Historique:
received: 24 03 2018
revised: 18 09 2018
accepted: 10 10 2018
pubmed: 18 11 2018
medline: 8 5 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

In 2016, 2.1 million people in the United States were estimated to have an opioid use disorder. Although the disorder can be safely and effectively treated with prescription methadone, treatment is potentially long term and may span women's peak childbearing ages. Little is known about women's reproductive health needs while on methadone. We interviewed 22 sexually active, nonpregnant women ages 21-39 years at two Los Angeles methadone clinics in 2016. The interviews were transcribed and coded by four researchers using thematic and open coding techniques. One-half of the women were nulliparous and 17 were in stable, monogamous relationships with men. Women reported a range of feelings and perceptions about pregnancy, but nearly all wanted to delay pregnancy until discontinuing methadone. However, many women indicated limited interest in preventing pregnancy because of the relative stability of their relationships, fear of infertility, and low perceived risk of pregnancy. These factors influenced contraceptive use. Women described mixed feelings about pregnancy and many ultimately felt that an unplanned pregnancy would be acceptable in the context of their relationships and uncertain fertility. These findings provide context for previous quantitative findings that women in methadone treatment have higher rates of unintended pregnancy and lower rates of contraceptive use than the general population. Accurate information about pregnancy in the context of methadone treatment may help women to make proactive family planning decisions. Health care providers should discuss the guidelines for pregnancy on methadone and offer a range of options to help women achieve their reproductive goals.

Identifiants

pubmed: 30446331
pii: S1049-3867(18)30172-5
doi: 10.1016/j.whi.2018.10.004
pmc: PMC6424631
mid: NIHMS1509745
pii:
doi:

Substances chimiques

Contraceptive Agents 0
Methadone UC6VBE7V1Z

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

176-181

Subventions

Organisme : NICHD NIH HHS
ID : P2C HD041022
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD007545
Pays : United States

Informations de copyright

Copyright © 2018 Jacobs Institute of Women's Health. Published by Elsevier Inc. All rights reserved.

Références

Mt Sinai J Med. 2000 Oct-Nov;67(5-6):347-64
pubmed: 11064485
Arch Gen Psychiatry. 2001 May;58(5):503-8
pubmed: 11343531
J Addict Dis. 2002;21(4):47-53
pubmed: 12296501
Psychopharmacology (Berl). 2002 Nov;164(2):121-37
pubmed: 12404074
Am J Addict. 2008 Sep-Oct;17(5):372-86
pubmed: 18770079
Addiction. 2008 Sep;103(9):1429-40
pubmed: 18783498
Endocr Rev. 2010 Feb;31(1):98-132
pubmed: 19903933
J Subst Abuse Treat. 2011 Mar;40(2):199-202
pubmed: 21036512
J Addict Dis. 2011 Jan;30(1):27-38
pubmed: 21218308
Addict Behav. 2011 Dec;36(12):1184-90
pubmed: 21835551
Pediatrics. 2012 Feb;129(2):e540-60
pubmed: 22291123
J Health Polit Policy Law. 2013 Apr;38(2):299-343
pubmed: 23262772
Drug Alcohol Depend. 2013 Jul 1;131(1-2):23-35
pubmed: 23490450
Clin Perinatol. 2013 Sep;40(3):337-50
pubmed: 23972743
Psychiatr Serv. 2014 Feb 1;65(2):146-57
pubmed: 24248468
Prev Med. 2015 Nov;80:23-31
pubmed: 25900803
J Emerg Med. 2015 Dec;49(6):871-7
pubmed: 26409674
J Addict Med. 2016 Jan-Feb;10(1):20-5
pubmed: 26690290
N Engl J Med. 2016 Mar 3;374(9):843-52
pubmed: 26962904
Subst Use Misuse. 2016 Sep 18;51(11):1477-83
pubmed: 27440391
MMWR Recomm Rep. 2016 Jul 29;65(3):1-103
pubmed: 27467196
Obstet Gynecol Clin North Am. 2017 Mar;44(1):95-107
pubmed: 28160896
Obstet Gynecol. 2017 Aug;130(2):e81-e94
pubmed: 28742676
J Subst Abuse Treat. 2018 Apr;87:79-85
pubmed: 29433788
Lancet. 2018 Jul 7;392(10141):9-11
pubmed: 30047402

Auteurs

Marta Bornstein (M)

Department of Community Health Sciences, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California; California Center for Population Research, University of California, Los Angeles, Los Angeles, California. Electronic address: mbornstein@ucla.edu.

Jessica D Gipson (JD)

Department of Community Health Sciences, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California; California Center for Population Research, University of California, Los Angeles, Los Angeles, California.

Roselle Bleck (R)

David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.

Aparna Sridhar (A)

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.

Agatha Berger (A)

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Department of Obstetrics and Gynecology, Christiana Care Health System, Newark, Delaware.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH